Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | RAB9A | P51151 | 4/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7741406 | 0.88 | DRD2 (0.44) | TSHRRAB9AMAPTNPC1SMN1; SMN2 | |
| SCHEMBL7740984 | 0.87 | TBXA2R (0.38) | TSHRRAB9AL3MBTL1MAPTTP53 | |
| SCHEMBL7745478 | 0.85 | GRM2 (0.41) | TSHRRAB9AL3MBTL1MAPTTP53 | |
| SCHEMBL7746299 | 0.84 | TSHR (0.40) | TSHRRAB9AMAPTTP53NPC1 | |
| SCHEMBL7746271 | 0.83 | TSHR (0.45) | TSHRRAB9AL3MBTL1TP53NPC1 | |
| SCHEMBL7745732 | 0.81 | TSHR (0.46) | TSHRL3MBTL1MAPTTP53KMT2A | |
| SCHEMBL7740965 | 0.80 | TSHR (0.49) | TSHRRAB9AL3MBTL1TP53NPC1 | |
| SCHEMBL7745634 | 0.79 | ALDH1A1 (0.37) | TSHRMAPTKMT2ASMN1; SMN2PTK2B | |
| SCHEMBL7741370 | 0.79 | TSHR (0.43) | TSHRRAB9AMAPTKMT2AALDH1A1 | |
| SCHEMBL7745254 | 0.78 | TSHR (0.41) | TSHRMAPTKMT2AALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6774134-B2 | FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION | BRISTOL-MYERS SQUIBB COMPANY | 2004-08-10 | — | — | US | disclosed |
| US-6774134-B2 | FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION | BRISTOL-MYERS SQUIBB COMPANY | 2004-08-10 | — | — | US | disclosed |